Breaking News, Promotions & Moves

Aptuit

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Aptuit, Inc. has appointed Dr. Michael J. Butler president, scientific operations of its drug development services. He will assume responsibility for all of Aptuit’s scientific operations, which span API development, preclinical technologies, analytics, and pharmaceutics, consisting of more than 875 scientists and technical staff in Kansas City, MO and Edinburgh, Scotland. Dr. Butler has 20 years of experience in pharmaceutical drug development. He most recently served as group vice p...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters